Charles River Laboratories has acquired Agilux Laboratories, Inc., a Worcester, MA-based CRO that provides discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services. Agilux was acquired from a holding company controlled by the company’s founders and sole investor, Ampersand Capital Partners.   The acquisition adds integrated discovery capabilities to Charles River’s nonclinical portfolio. Charles River believes the...